Panelists Discuss Global Health Law, Innovation, Access, Justice

Intellectual Property Watch reports on a roundtable on global health law, innovation, access and justice, hosted last week by the Geneva-based Graduate Institute of International and Development Studies and Georgetown Law School. “At issue is the capacity of the pharmaceutical industry to innovate, and the potential barriers to access in a context of widespread diseases that blur the boundaries between developed and developing countries,” the news service writes, noting, “Most panelists concluded that governments should hold primary responsibility for the health of their populations” (Saez, 10/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.